The Mission of the Reynolds Family Spine Laboratory is:
- To perform cutting-edge research in order to develop novel therapies that treat chronic spinal cord injury (SCI) by combining multidisciplinary basic, translational and clinical research and to translate the findings into clinical interventions that improve motor, sensory, and autonomic functions while minimizing spasticity and neuropathic pain
- To train innovative, enthusiastic, and passionate future scientists and clinician-scientists who will bring creative new perspectives into the field and to encourage young investigators from different relevant scientific backgrounds to engage in high-impact SCI research
- To increase the dialogue and collaboration between scientists, clinician-scientists, clinicians and the pharmaceutical industry in order to expedite the development, approval, and implementation of new therapies
- To bring public awareness to the challenges presented by SCI and its treatment and to increase advocacy for individuals with SCI and their families through the advancement of SCI research
- To deliver all of our research into the public domain.
Our research aims to improve the functional outcomes of chronic and acute spinal cord injury and central nervous system diseases that can lead to paralysis. Our investigations bridge basic science and pre-clinical research and utilize combinatorial strategies comprising neurosurgery, molecular and cellular neurobiology, histology and behavioral approaches.
The Laboratory collaborates with other investigators in the fields of immunology, proteomics and neurobiology of disease. The team, consisting of co-directors Robert F. Heary, MD and Stella Elkabes, PhD, post-doctoral fellows, graduate and medical students, and staff members integrates interdisciplinary skills and experience to identify targets for therapeutic interventions and to translate the findings from the bench to the bedside.